HSD17B13-IN-3
HSD17B13-IN-3 (compound 2) is a potent hydroxysteroid 17ß-dehydrogenase 13 (HSD17B13) inhibitor with IC50s of 0.38 μM and 0.45 μM in biochemical assays using both β-estradiol or Leukotriene B4 (LTB4) as substrate and NAD+ as cofactor. HSD17B13-IN-3 shows low cell penetration[1].
Product Specifications
CAS Number
[313259-88-0]
UNSPSC
12352005
Target
17β-HSD
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/hsd17b13-in-3.html
Concentration
10mM
Purity
99.78
Solubility
DMSO : 260 mg/mL (ultrasonic)
Smiles
CC1=C(S(C2=CC=C(C)C=C2)(=O)=O)C=C(C)C=C1S(=O)(NC3=CC=C(C(O)=O)C=C3)=O
Molecular Formula
C22H21NO6S2
Molecular Weight
459.54
References & Citations
[1]Liu S, et, al. Structural basis of lipid-droplet localization of 17-beta-hydroxysteroid dehydrogenase 13. Nat Commun. 2023 Aug 24;14 (1) :5158.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
PD-L1 tested non-small cell lung cancer tissue array, which is suitable for tumor immunotherapy, including pathology grade, TNM, clinical stage and PD-L1(Sp263) information, 4 cases/4 core, replacing LC04
